Chemosensitizing Effects of Resveratrol Derivatives on p53-dependent Apoptosis Triggered by Cisplatin in Human Lung Cancer Cells
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
BACKGROUND/AIM: Although cisplatin is a standard treatment for lung cancer, its effectiveness is often limited by tumor chemoresistance and severe side effects, driving the search for approaches that can restore drug sensitivity. Resveratrol (Res) exhibits anticancer properties, but its clinical application is hindered by poor stability and low bioavailability. This study investigated the chemosensitization effect of YI-7, a Res derivative with modified pharmacophore benzyloxy substitutions that sensitized to p53-dependent apoptosis triggered by cisplatin in human lung cancer cells. MATERIALS AND METHODS: of YI-7 in A549 human lung cancer cells was determined using the MTT viability assay. Cell proliferation was further examined using a colony formation assay. Chemosensitizing effects were assessed by pretreating cells with cisplatin (25 μM), followed by YI-7, and analyzing cell viability (MTT), nuclear staining (Hoechst 33342/PI), and apoptosis-associated proteins using western blot. RESULTS: 137.90±11.48 μM) and dose-dependently inhibited colony formation, with marked suppression at 50 μM. Moreover, YI-7 pretreatment synergistically enhanced cisplatin cytotoxicity in A549 cells, with Combination Index (CI) values
Fields of Study & Subjects
Sirtuins and Resveratrol in Medicine
Cancer-related Molecular Pathways
Histone Deacetylase Inhibitors Research
Publication details
- Journal / source
- Anticancer Research
- Volume
- 46
- Issue
- 4
- Pages
- 1893–1901
- Publication date
- 27 March 2026
- Language
- EN